568 related articles for article (PubMed ID: 33316806)
1. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
Herth FJF; Sakoulas G; Haddad F
Respiration; 2020; 99(12):1145-1153. PubMed ID: 33316806
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
Tabarsi P; Barati S; Jamaati H; Haseli S; Marjani M; Moniri A; Abtahian Z; Dastan A; Yousefian S; Eskandari R; Saffaei A; Monjazebi F; Vahedi A; Dastan F
Int Immunopharmacol; 2021 Jan; 90():107205. PubMed ID: 33214093
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study.
Ali HS; Elshafei MS; Saad MO; Mitwally HA; Al Wraidat M; Aroos A; Shaikh N; Ananthegowda DC; Abdelaty MA; George S; Nashwan AJ; Mohamed AS; Khatib MY
BMC Pulm Med; 2021 Nov; 21(1):354. PubMed ID: 34743710
[TBL] [Abstract][Full Text] [Related]
4. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
5. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis.
Tan E; Song J; Deane AM; Plummer MP
Chest; 2021 Feb; 159(2):524-536. PubMed ID: 33069725
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH).
Díaz E; Amézaga Menéndez R; Vidal Cortés P; Escapa MG; Suberviola B; Serrano Lázaro A; Marcos Neira P; Quintana Díaz M; Catalán González M
Med Intensiva (Engl Ed); 2021 Mar; 45(2):104-121. PubMed ID: 32854988
[TBL] [Abstract][Full Text] [Related]
7. What if COVID-19 affects the child: which weapons and how to use them.
Anedda L; Bianchini L; Cuzzolin L; Finco G; Fanos V; Marcialis MA
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3325-3337. PubMed ID: 33928620
[TBL] [Abstract][Full Text] [Related]
8. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
; Pan H; Peto R; Henao-Restrepo AM; Preziosi MP; Sathiyamoorthy V; Abdool Karim Q; Alejandria MM; Hernández García C; Kieny MP; Malekzadeh R; Murthy S; Reddy KS; Roses Periago M; Abi Hanna P; Ader F; Al-Bader AM; Alhasawi A; Allum E; Alotaibi A; Alvarez-Moreno CA; Appadoo S; Asiri A; Aukrust P; Barratt-Due A; Bellani S; Branca M; Cappel-Porter HBC; Cerrato N; Chow TS; Como N; Eustace J; García PJ; Godbole S; Gotuzzo E; Griskevicius L; Hamra R; Hassan M; Hassany M; Hutton D; Irmansyah I; Jancoriene L; Kirwan J; Kumar S; Lennon P; Lopardo G; Lydon P; Magrini N; Maguire T; Manevska S; Manuel O; McGinty S; Medina MT; Mesa Rubio ML; Miranda-Montoya MC; Nel J; Nunes EP; Perola M; Portolés A; Rasmin MR; Raza A; Rees H; Reges PPS; Rogers CA; Salami K; Salvadori MI; Sinani N; Sterne JAC; Stevanovikj M; Tacconelli E; Tikkinen KAO; Trelle S; Zaid H; Røttingen JA; Swaminathan S
N Engl J Med; 2021 Feb; 384(6):497-511. PubMed ID: 33264556
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics and outcome of 70 ventilated COVID-19 patients : Summary after the first wave at a university center].
Schroeder I; Scharf C; Zoller M; Wassilowsky D; Frank S; Stecher SS; Stemmler J; Kneidinger N; Peterß S; Zwißler B; Irlbeck M
Anaesthesist; 2021 Jul; 70(7):573-581. PubMed ID: 33369696
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
Kim MS; An MH; Kim WJ; Hwang TH
PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
[TBL] [Abstract][Full Text] [Related]
11. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study.
Aggarwal R; Dewan A; Pandey A; Trehan N; Majid MA
Int Immunopharmacol; 2022 May; 106():108615. PubMed ID: 35168081
[TBL] [Abstract][Full Text] [Related]
13. The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients': a retrospective, multi-centric cohort study.
Salehi M; Barkhori Mehni M; Akbarian M; Fattah Ghazi S; Khajavi Rad N; Moradi Moghaddam O; Jamali Moghaddam S; Hosseinzadeh Emam M; Abtahi SH; Moradi M; Ghiasvand F
Eur J Med Res; 2022 Feb; 27(1):18. PubMed ID: 35115056
[TBL] [Abstract][Full Text] [Related]
14. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
15. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
[TBL] [Abstract][Full Text] [Related]
16. Severe COVID-19 Infections-Knowledge Gained and Remaining Questions.
Bos LDJ; Brodie D; Calfee CS
JAMA Intern Med; 2021 Jan; 181(1):9-11. PubMed ID: 32945833
[No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease.
Danieli MG; Piga MA; Paladini A; Longhi E; Mezzanotte C; Moroncini G; Shoenfeld Y
Scand J Immunol; 2021 Nov; 94(5):e13101. PubMed ID: 34940980
[TBL] [Abstract][Full Text] [Related]
18. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
[TBL] [Abstract][Full Text] [Related]
20. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
